Measurement of Potential Biomarkers Predicting Erlotinib Response.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 17 May 2017 Biomarkers information updated
- 17 May 2010 New trial record